# Nonmyeloablative Haploidentical Transplant Followed by MLN9708

> **NCT02169791** · PHASE2 · COMPLETED · sponsor: **Northside Hospital, Inc.** · enrollment: 29 (actual)

## Conditions studied

- Acute Leukemia
- Chronic Leukemia
- Myelodysplastic Syndrome
- Lymphomas
- Multiple Myeloma

## Interventions

- **DRUG:** MLN9708

## Key facts

- **NCT ID:** NCT02169791
- **Lead sponsor:** Northside Hospital, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07-15
- **Primary completion:** 2020-07-28
- **Final completion:** 2020-07-28
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2021-09-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02169791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02169791, "Nonmyeloablative Haploidentical Transplant Followed by MLN9708". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02169791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*